Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/13/2026

1. USO
2. BIIB
3. AAPL
4. SPY
5. IONS
6. FFAI
7. DIS
8. NFLX
9. QTTB
10. BW

Go back to Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant
NEPHROGENEX (NASDAQ: NRX) Delayed: 0.14 --0 (-0%)
Previous Close $0.14    52 Week High $8.90 
Open $0.04    52 Week Low $0.10 
Day High $0.14    P/E N/A 
Day Low $0.14    EPS $-0.55 
Volume 805,757